Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 376 participants.
Also called NCT02825134
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 376 participants
- Registry
-
NCT02825134
-
- Other papers using this trial's data
- Three-Year Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients With Tricuspid or Bicuspid Aortic Stenosis
- Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark, Finland, Iceland, Norway, Sweden
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02825134. Randomized; single masking; primary purpose treatment. Start 2016-06-30 (actual); primary completion 2024-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis
- Acronym
- NOTION-2
- Condition
- Aortic Valve Stenosis
- Condition
- Cardiovascular Diseases
- Condition
- Heart Diseases
- Condition
- Heart Valve Diseases
- Condition
- Ventricular Outflow Obstruction
- Intervention (Device)
- Transcatheter aortic valve replacement
- Intervention (Device)
- Surgical aortic valve replacement
- Lead sponsor
- Ole De Backer
- Collaborator
- Symetis SA
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Abbott
- Collaborator
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct02825134- Content hash
da55c268a81c0da0088d1f04b4cc78313d9102f68a59c2a5b3194f53ce7911fb